A double-blind randomized phase II study of 10 versus 5 mg olanzapine for emesis induced by highly emetogenic chemotherapy with cisplatin.

Hironobu Hashimoto; Takako Yanai; Kengo Nagashima; Natsuko Okita Tsuda; Hidehito Horinouchi; Tomomi Takiguchi; Fumiyoshi Ohyanagi; Masahiko Nakao; Koji Takeda; Toshiaki Nakayama; Hiroshi Sakai; Takahiro Arai; Koichi Minato; Yuki Kogure; Daijiro Harada; Kenichi Suzuki; Narikazu Boku; Yasuhiro Shimada; Satoru Iwasa; Noboru Yamamoto

doi:10.1200/jco.2016.34.15_suppl.10111

A double-blind randomized phase II study of 10 versus 5 mg olanzapine for emesis induced by highly emetogenic chemotherapy with cisplatin.

Journal of Clinical Oncology ◽

10.1200/jco.2016.34.15_suppl.10111 ◽

2016 ◽

Vol 34 (15_suppl) ◽

pp. 10111-10111 ◽

Cited By ~ 6

Author(s):

Hironobu Hashimoto ◽

Takako Yanai ◽

Kengo Nagashima ◽

Natsuko Okita Tsuda ◽

Hidehito Horinouchi ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Emetogenic Chemotherapy ◽

Highly Emetogenic Chemotherapy ◽

Double Blind ◽

Randomized Phase Ii

Download Full-text

A double-blind randomized Phase II study of olanzapine 10 mg versus 5 mg for emesis induced by highly emetogenic chemotherapy

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyu191 ◽

2014 ◽

Vol 45 (2) ◽

pp. 229-231 ◽

Cited By ~ 3

Author(s):

K. Nagashima ◽

S. Iwasa ◽

T. Yanai ◽

H. Hashimoto ◽

K. Suzuki ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Emetogenic Chemotherapy ◽

Highly Emetogenic Chemotherapy ◽

Double Blind ◽

Randomized Phase Ii

Download Full-text

A dose-finding randomized Phase II study of oral netupitant in combination with palonosetron .75 mg intravenous for the prevention of chemotherapy-induced nausea and vomiting in Japanese patients receiving highly emetogenic chemotherapy

Japanese Journal of Clinical Oncology ◽

10.1093/jjco/hyy161 ◽

2018 ◽

Vol 49 (2) ◽

pp. 121-129 ◽

Cited By ~ 4

Author(s):

Akihiko Osaki ◽

Kenichi Inoue ◽

Hiroshi Sakai ◽

Kazuhiko Yamada ◽

Koichi Minato ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Japanese Patients ◽

Emetogenic Chemotherapy ◽

Nausea And Vomiting ◽

Dose Finding ◽

Highly Emetogenic Chemotherapy ◽

Randomized Phase Ii

Download Full-text

Faculty of 1000 evaluation for A Double-Blind, Randomized Phase II Study to Evaluate the Safety and Efficacy of Acetyl-L-Carnitine in the Prevention of Sagopilone-Induced Peripheral Neuropathy.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.718136956.793486581 ◽

2013 ◽

Author(s):

Steve Plaxe ◽

Kristy Ward

Keyword(s):

Peripheral Neuropathy ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Safety And Efficacy ◽

Randomized Phase Ii

Download Full-text

Double-blind randomized phase II study of hyperbaric oxygen in patients with radiation-induced brachial plexopathy

Radiotherapy and Oncology ◽

10.1016/s0167-8140(00)00319-4 ◽

2001 ◽

Vol 58 (3) ◽

pp. 279-286 ◽

Cited By ~ 61

Author(s):

Joyce Pritchard ◽

Praveen Anand ◽

Jon Broome ◽

Carol Davis ◽

Lone Gothard ◽

...

Keyword(s):

Hyperbaric Oxygen ◽

Phase Ii ◽

Phase Ii Study ◽

Brachial Plexopathy ◽

Double Blind ◽

Randomized Phase Ii ◽

Radiation Induced

Download Full-text

Biomarkers for immunotherapy: Results from the analysis of an HLA-status double-blind, biologically randomized phase II study of five therapeutic epitope-peptides with oxaliplatin-based chemotherapy as first-line therapy for advanced colorectal cancer (FXV study).

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.3038 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 3038-3038

Author(s):

Shoichi Hazama ◽

Yusuke Nakamura ◽

Hiroaki Tanaka ◽

Ko Tahara ◽

Ryoichi Shimizu ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Advanced Colorectal Cancer ◽

Phase Ii Study ◽

First Line ◽

Double Blind ◽

First Line Therapy ◽

Line Therapy ◽

Randomized Phase Ii

Download Full-text

38 Influence of amifostine on neuroprotection in 1st-line treatment of advanced ovarian cancer with carboplatin/taxane-based chemotherapy - a double-blind, placebo-controlled, randomized phase II-study from the AGO Ovarian Cancer Study Group

European Journal of Cancer Supplements ◽

10.1016/s1359-6349(03)90072-3 ◽

2003 ◽

Vol 1 (5) ◽

pp. S15-S16

Author(s):

P. Wimberger ◽

R. Kimmig ◽

F. Hilpert ◽

A. Stähle ◽

A. Burges ◽

...

Keyword(s):

Ovarian Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Advanced Ovarian Cancer ◽

Study Group ◽

Line Treatment ◽

Double Blind ◽

Double Blind Placebo ◽

Cancer Study Group ◽

Randomized Phase Ii

Download Full-text

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-015-2767-y ◽

2015 ◽

Vol 76 (1) ◽

pp. 97-103 ◽

Cited By ~ 34

Author(s):

Chu Matsuda ◽

Yoshinori Munemoto ◽

Hideyuki Mishima ◽

Naoki Nagata ◽

Mitsuru Oshiro ◽

...

Keyword(s):

Colorectal Cancer ◽

Phase Ii ◽

Cancer Chemotherapy ◽

Oral Mucositis ◽

Phase Ii Study ◽

Double Blind ◽

Double Blind Placebo ◽

Randomized Phase Ii

Download Full-text

Faculty Opinions recommendation of Vandetanib versus gefitinib in patients with advanced non-small-cell lung cancer: results from a two-part, double-blind, randomized phase ii study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1158694.618908 ◽

2009 ◽

Author(s):

Ross Cagan

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Phase Ii ◽

Cell Lung Cancer ◽

Phase Ii Study ◽

Small Cell ◽

Small Cell Lung ◽

Double Blind ◽

Randomized Phase Ii

Download Full-text

Oral ondansetron is highly active as rescue antiemetic treatment for moderately emetogenic chemotherapy: results of a randomized phase II study

Supportive Care in Cancer ◽

10.1007/s00520-008-0438-9 ◽

2008 ◽

Vol 16 (12) ◽

pp. 1375-1380 ◽

Cited By ~ 10

Author(s):

Alessandra Fabi ◽

Mariangela Ciccarese ◽

Giulio Metro ◽

Antonella Savarese ◽

Diana Giannarelli ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Emetogenic Chemotherapy ◽

Moderately Emetogenic Chemotherapy ◽

Highly Active ◽

Antiemetic Treatment ◽

Randomized Phase Ii ◽

Oral Ondansetron ◽

Rescue Antiemetic

Download Full-text

Double blind randomized phase II study with radiation+5-fluorouracil±celecoxib for resectable rectal cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2009.08.006 ◽

2009 ◽

Vol 93 (2) ◽

pp. 273-278 ◽

Cited By ~ 28

Author(s):

Annelies Debucquoy ◽

Sarah Roels ◽

Laurence Goethals ◽

Louis Libbrecht ◽

Eric Van Cutsem ◽

...

Keyword(s):

Rectal Cancer ◽

Phase Ii ◽

Phase Ii Study ◽

Double Blind ◽

Resectable Rectal Cancer ◽

Randomized Phase Ii

Download Full-text